Therapeutic use of TP5 (thymopoietin 32–36) in sarcoidosis of the skin
- 1 March 1983
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 26 (3) , 350-360
- https://doi.org/10.1016/0090-1229(83)90119-8
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Immunoregulation in sarcoidosisClinical Immunology and Immunopathology, 1981
- Alteration of T-lymphocyte subpopulations in sarcoidosisClinical Immunology and Immunopathology, 1978
- 127. The multitest system for assay of delayed cutaneous hypersensitivity (DCH) to ubiquitous antigensJournal of Allergy and Clinical Immunology, 1978
- Humoral and Cellular Immunity in SarcoidosisActa Medica Scandinavica, 1978
- T and B lymphocytes in sarcoidosis: a clinical correlation.Thorax, 1976
- THE NATURE AND MECHANISM OF STIMULATION OF IMMUNE RESPONSIVENESS BY THYMUS EXTRACTSAnnals of the New York Academy of Sciences, 1975
- ISOLATION, BIOCHEMICAL CHARACTERISTICS, AND BIOLOGICAL ACTIVITY OF A CIRCULATING THYMIC HORMONE IN THE MOUSE AND IN THE HUMANAnnals of the New York Academy of Sciences, 1975
- Immunochemical quantitation of antigens by single radial immunodiffusionImmunochemistry, 1965
- IN-VITRO STUDIES OF LYMPHOCYTES FROM PATIENTS WITH SARCOIDOSIS AND LYMPHOPROLIFERATIVE DISEASESThe Lancet, 1964
- STUDIES ON THE ROLE OF THE THYMUS IN IMMUNOBIOLOGYThe Journal of Experimental Medicine, 1963